-transparent.png){kind=logo}
The c-fms protooncogene product was identified as the CSF-1 or M-CSF receptor, a polypeptide growth factor that plays a major role in myelomonocytic differentiation. This led us to look for expression of c-fms in fresh acute myeloid leukemia (AML) cells, using Northern blot analysis. c-fms expression was found in the leukemic cells of 28 AML patients, regardless of their stage of differentiation, which was assessed in the French-American-British (FAB) classification. However, the level of c-fms expression was especially high in AML of the M5 stage. High levels of expression were not accompanied by either amplification or rearrangements of the c-fms gene in AML cell DNAs. In contrast, c-fms expression was not found in acute lymphoid leukemias, whether of T or B origin. Thus, c-fms expression appears as a specific molecular marker of leukemogenesis in the myeloid lineage.
P Dubreuil, and
H Torrès, and
M A Courcoul, and
F Birg, and
P Mannoni
January 2002,
Experimental hematology,
P Dubreuil, and
H Torrès, and
M A Courcoul, and
F Birg, and
P Mannoni
November 1992,
Blood,
P Dubreuil, and
H Torrès, and
M A Courcoul, and
F Birg, and
P Mannoni
October 1999,
Seminars in hematology,
P Dubreuil, and
H Torrès, and
M A Courcoul, and
F Birg, and
P Mannoni
May 1992,
Cancer research,
P Dubreuil, and
H Torrès, and
M A Courcoul, and
F Birg, and
P Mannoni
November 2003,
British journal of haematology,
P Dubreuil, and
H Torrès, and
M A Courcoul, and
F Birg, and
P Mannoni
January 1991,
Pathobiology : journal of immunopathology, molecular and cellular biology,
P Dubreuil, and
H Torrès, and
M A Courcoul, and
F Birg, and
P Mannoni
July 2020,
Haematologica,
P Dubreuil, and
H Torrès, and
M A Courcoul, and
F Birg, and
P Mannoni
September 1991,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
P Dubreuil, and
H Torrès, and
M A Courcoul, and
F Birg, and
P Mannoni
January 1990,
Leukemia research,
P Dubreuil, and
H Torrès, and
M A Courcoul, and
F Birg, and
P Mannoni
January 1987,
Blood,
